HK1014986A1 - Production of enzymatically active recombinant carboxypeptidase b - Google Patents

Production of enzymatically active recombinant carboxypeptidase b

Info

Publication number
HK1014986A1
HK1014986A1 HK98119240A HK98119240A HK1014986A1 HK 1014986 A1 HK1014986 A1 HK 1014986A1 HK 98119240 A HK98119240 A HK 98119240A HK 98119240 A HK98119240 A HK 98119240A HK 1014986 A1 HK1014986 A1 HK 1014986A1
Authority
HK
Hong Kong
Prior art keywords
procpb
enzymatically active
production
active recombinant
active cpb
Prior art date
Application number
HK98119240A
Other languages
English (en)
Inventor
Jacob Hartman
Netta Fulga
Simona Mendelovitch
Marian Gorecki
Original Assignee
Ferring Int Ct Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Int Ct Sa filed Critical Ferring Int Ct Sa
Publication of HK1014986A1 publication Critical patent/HK1014986A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK98119240A 1995-01-25 1998-12-30 Production of enzymatically active recombinant carboxypeptidase b HK1014986A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37823395A 1995-01-25 1995-01-25
PCT/US1996/000995 WO1996023064A1 (en) 1995-01-25 1996-01-25 Production of enzymatically active recombinant carboxypeptidase b

Publications (1)

Publication Number Publication Date
HK1014986A1 true HK1014986A1 (en) 1999-10-08

Family

ID=23492292

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98119240A HK1014986A1 (en) 1995-01-25 1998-12-30 Production of enzymatically active recombinant carboxypeptidase b

Country Status (22)

Country Link
US (1) US5948668A (de)
EP (1) EP0871718B1 (de)
JP (1) JP4250716B2 (de)
KR (1) KR100566136B1 (de)
CN (1) CN1144874C (de)
AT (1) ATE358717T1 (de)
AU (1) AU698889B2 (de)
BR (1) BR9606795A (de)
CA (1) CA2210242C (de)
CZ (1) CZ292541B6 (de)
DE (1) DE69637011T2 (de)
DK (1) DK0871718T3 (de)
ES (1) ES2284167T3 (de)
HK (1) HK1014986A1 (de)
HU (1) HU225673B1 (de)
IL (1) IL116696A (de)
MX (1) MX9705279A (de)
NZ (1) NZ302874A (de)
PL (1) PL183228B1 (de)
PT (1) PT871718E (de)
WO (1) WO1996023064A1 (de)
ZA (1) ZA96515B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ315713A (en) 1995-08-16 1999-08-30 Zeneca Ltd A conjugate comprising an antibody as targeting moiety linked to a carboxypeptidase b (cpb)
CN1896231B (zh) 1998-08-06 2012-09-05 山景药品公司 分离四聚体尿酸氧化酶的方法
US20040117863A1 (en) * 1998-09-18 2004-06-17 Edge Michael D. Transgenically produced fusion proteins
DE19915938A1 (de) 1999-04-09 2000-10-19 Aventis Pharma Gmbh Herstellung von pankreatischer Procarboxypeptidase B, Isoformen und Muteinen davon und ihre Verwendung
US6441153B1 (en) 1999-09-29 2002-08-27 Lexicon Genetics Incorporated Human carboxypeptidases and polynucleotides encoding the same
CN1414970A (zh) * 1999-09-17 2003-04-30 Gtc生物治疗学公司 以转基因方式生产的融合蛋白
EP1632575B1 (de) * 1999-09-29 2009-01-28 Lexicon Pharmaceuticals, Inc. Humane Carboxypeptidasen und diese kodierende Polynukleotide
AU2001229253A1 (en) * 2000-01-12 2001-07-24 Eli Lilly And Company Carboxypeptidase b free of animal products and contaminating enyzme activity
EP1538203B1 (de) * 2003-12-05 2010-01-20 Roche Diagnostics GmbH Rekombinante Carboxypeptidase B und ihre Aufreinigung
JP4411192B2 (ja) * 2003-12-05 2010-02-10 エフ.ホフマン−ラ ロシュ アーゲー 組換えで発現されるカルボキシペプチダーゼbおよびその精製
SI1794294T1 (sl) * 2004-09-27 2011-11-30 Sanofi Aventis Deutschland Rekombinantna karboksipeptidaza B
US20080159976A1 (en) * 2005-04-11 2008-07-03 Jacob Hartman Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
BRPI0612942A2 (pt) 2005-04-11 2012-10-09 Savient Pharmaceuticals Inc forma variante de oxidase de urato e uso do mesmo
LT3321359T (lt) 2005-04-11 2021-05-10 Horizon Pharma Rheumatology Llc Urato oksidazės variantinės formos ir jų panaudojimas
JP2008545665A (ja) * 2005-05-23 2008-12-18 ユニベルシテ ドゥ ジュネーブ 高体温による処置のための注入可能な超常磁性ナノ粒子および高体温インプラントを形成するための使用
EP2013225B1 (de) 2006-04-12 2014-12-17 Crealta Pharmaceuticals LLC Proteinaufreiningung mit hilfe von kationischen tensiden
CN101058805B (zh) * 2007-03-21 2011-09-07 北京贯虹科技有限公司 突变羧肽酶原b及突变羧肽酶b的生产方法
US8993714B2 (en) * 2007-10-26 2015-03-31 Imiplex Llc Streptavidin macromolecular adaptor and complexes thereof
US9102526B2 (en) 2008-08-12 2015-08-11 Imiplex Llc Node polypeptides for nanostructure assembly
US9285363B2 (en) 2009-05-11 2016-03-15 Imiplex Llc Method of protein nanostructure fabrication
HUP1200205A3 (en) 2009-06-25 2012-09-28 Savient Pharmaceuticals Method and kits for perdicting infusion reaction risk and antibody-mediated low of response by monitoring serum uric acid during pegylated uricare therapy
CN101967467B (zh) * 2009-07-28 2012-11-14 上海雅心生物技术有限公司 一种高稳定性的重组羧肽酶b的生产及应用
US11918624B2 (en) * 2020-06-10 2024-03-05 Kelsius Laboratories LLC Therapeutic composition for use in the treatment of COVID-19 and other cytokine storm associated disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK124483B (da) * 1967-12-04 1972-10-23 Bayer Ag Fremgangsmåde til rensning af carboxypeptidase B.
US4511503A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
HU190129B (en) * 1983-07-11 1986-08-28 Reanal Finomvegyszergyar,Hu Process for the isolation of carboxypeptidase b enzyme from mammal pancreas
US5206161A (en) * 1991-02-01 1993-04-27 Genentech, Inc. Human plasma carboxypeptidase B
FR2692907B1 (fr) * 1992-06-25 1995-06-30 Rhone Poulenc Rorer Sa Levures kluyveromyces modifiees, preparation et utilisation.
JP3472587B2 (ja) * 1992-08-28 2003-12-02 アベンティス ファーマ株式会社 骨関連カルボキシペプチダーゼ様タンパク質およびその製造法
EP0776369A4 (de) * 1993-11-16 2000-11-22 Lilly Co Eli Fuer die pankreas - carboxypeptidan - b aus schweinen kodierende dna - sequenzen

Also Published As

Publication number Publication date
EP0871718B1 (de) 2007-04-04
PT871718E (pt) 2007-06-26
HUP9800091A3 (en) 2004-03-29
KR100566136B1 (ko) 2006-11-10
EP0871718A1 (de) 1998-10-21
EP0871718A4 (de) 2000-06-07
DE69637011D1 (de) 2007-05-16
IL116696A0 (en) 1996-05-14
KR19980701652A (ko) 1998-06-25
PL183228B1 (pl) 2002-06-28
CZ292541B6 (cs) 2003-10-15
PL321499A1 (en) 1997-12-08
JP4250716B2 (ja) 2009-04-08
NZ302874A (en) 1998-11-25
HUP9800091A2 (hu) 1998-05-28
JPH11503002A (ja) 1999-03-23
AU698889B2 (en) 1998-11-12
MX9705279A (es) 1998-06-30
HU225673B1 (en) 2007-06-28
BR9606795A (pt) 1997-12-30
US5948668A (en) 1999-09-07
CA2210242A1 (en) 1996-08-01
ES2284167T3 (es) 2007-11-01
CZ225897A3 (cs) 1998-10-14
ATE358717T1 (de) 2007-04-15
WO1996023064A1 (en) 1996-08-01
DK0871718T3 (da) 2007-07-02
CA2210242C (en) 2010-04-27
CN1177377A (zh) 1998-03-25
AU4903496A (en) 1996-08-14
ZA96515B (en) 1996-08-15
CN1144874C (zh) 2004-04-07
IL116696A (en) 1999-08-17
DE69637011T2 (de) 2007-12-13

Similar Documents

Publication Publication Date Title
HK1014986A1 (en) Production of enzymatically active recombinant carboxypeptidase b
ZA975573B (en) Method for producing xylitol.
DE60027765D1 (de) Verfahren zur herstellung von mechanischer pulpe
AU1155495A (en) Process for the preparation of non-cariogenic sugars
EP0869174A3 (de) Verfahren zur Kolonierung und Herstellung von Spel Restriktionsendonuclease
MX9605272A (es) Proceso para preparar nicotinamida.
GB9424567D0 (en) Process for the production of xylitol
WO1999058691A3 (en) Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
MY119738A (en) Process for the purification of an alkanolamine
SE9502077D0 (sv) Sätt att framställa klordioxid
ES2097103T1 (es) Metodo de producir almidon cationico.
WO1993018166A3 (en) PRODUCTION OF $i(ASPERGILLUS NIGER CATALASE-R)
EP0733711A3 (de) Methode zur Klonierung und Herstellung einer SacI Restriktionsendonuklease
EP1058739A4 (de) Methode zur erstellung von genexpressionsprofilen
EP0959131A3 (de) Verfahren zur Klonierung und Vorbereitung der AgeI Restriktions-Endonuklease in E. coli
FI962609A (fi) Menetelmä ksylitolin valmistamiseksi
TW375603B (en) Separation of 2-aminomethyl cyclopentylamine from a mixture comprising hexamethylenediamine and 2-aminomethyl cyclopentylamine
EP0324248A3 (de) Verfahren zur Herstellung von FnuDI-Restriktionsendonuklease und -methylase
EP0332406A3 (en) Method for producing the ase i restriction endonuclease and methylase
EP0780398A3 (de) Verfahren zur Reinigung von Tamm-Horsfall-Glykoprotein und Uromodulin, die gereinigten Produkte und ein Verfahren für die Unterscheidung beider Stoffe
EP0321268A3 (de) Verfahren zur Herstellung von BanI-Restriktionsendonuklease und -methylase
MX9603672A (es) Proceso para la produccion de una ciclosporina.
WO2001019989A3 (en) Method of producing and purifying endostatintm protein
GB9722481D0 (en) Expression system
WO1997016457A3 (de) Protein mit anti-tumorwirkung

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20160124